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Abstract
The content of sulfur amino acid (SAA) in a meal affects postprandial plasma cysteine concentrations and the redox
potential of cysteine/cystine. Because such changes can affect enzyme, transporter, and receptor activities, meal content
of SAA could have unrecognized effects on metabolism during the postprandial period. This pilot study used proton NMR
(1H-NMR) spectroscopy of human plasma to test the hypothesis that dietary SAA content changes macronutrient
metabolism. Healthy participants (18–36 y, 5 males and 3 females) were equilibrated for 3 d to adequate SAA, fed
chemically defined meals without SAA for 5 d (depletion), and then fed isoenergetic, isonitrogenous meals containing
56 mg×kg21×d21 SAA for 4.5 d (repletion). On the first and last day of consuming the chemically defined meals, a morning
meal containing 60% of the daily food intake was given and plasma samples were collected over an 8-h postprandial time
course for characterization of metabolic changes by 1H-NMR spectroscopy. SAA-free food increased peak intensity in the
plasma 1H-NMR spectra in the postprandial period. Orthogonal signal correction/partial least squares-discriminant analysis
showed changes in signals associated with lipids, some amino acids, and lactate, with notable increases in plasma lipid
signals (TG, unsaturated lipid, cholesterol). Conventional lipid analyses confirmed higher plasma TG and showed an
increase in plasma concentration of the lipoprotein lipase inhibitor, apoC-III. The results show that plasma 1H-NMR spectra
can provide useful macronutrient profiling following a meal challenge protocol and that a single meal with imbalanced SAA
content alters postprandial lipid metabolism. J. Nutr. 141: 1424–1431, 2011.
Introduction
Variation in metabolism of sulfur amino acids (SAA)10 has been
implicated in cardiovascular disease (CVD). For instance,
individuals with homocysteinemia have accelerated CVD (1,2)
and high plasma total homocysteine has been associated with
increased risk of CVD in several studies (1–4). High plasma
cystine (CySS) and redox potentials for Cys/CySS and glutathi-
one/glutathione disulfide have also been associated with CVD
risk factors, including increased carotid intima media thickness
(5), decreased flow mediated dilation (6), reversible myocardial
perfusion defects (7), and persistent atrial fibrillation (8).
Currently, however, there is no consensus concerning mecha-
nisms relating SAA metabolites and CVD development.
One of the obstacles to elucidation of the underlying mech-
anisms is that clinical data are largely obtained under fasting
conditions while individuals are in a postprandial state most of
the day. Hence, an understanding of the metabolic responses to
dietary SAA during the postprandial period could be useful to
determine the roles of SAA in CVD development. Such informa-
tion can be obtained from challenge studies where effects of
variation in diet can be measured. Although such studies cannot
directly establish causation in disease, they can reveal cause-effect
relationships between diet and blood variables, which can then be
used to design nutritional intervention trials.
In a diurnal variation study, we found that Cys, CySS,
glutathione, and the redox potential for Cys/CySS varied in
temporal patterns suggestive of meal-related changes (9), which
was confirmed by meal challenges without and with SAA (10). In
a subset of participants from the diurnal variation study, proton
NMR (1H-NMR) spectroscopy of plasma showed the ability to
discriminate metabolic patterns of macronutrients (blood lipids,
amino acids, glucose) within participants (11). Fractal analysis
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of this data revealed that the metabolic patterns could predict
plasma Cys concentration (12). Thus, the data show that, in
principle, 1H-NMR spectroscopy of human plasma can provide
an approach to gain understanding of metabolic changes asso-
ciated with dietary SAA intake.
1H-NMR spectroscopy has been used to measure biologic
responses to nutritional deficiency or excess in a number of studies
(13–15). The spectra have some overlap of signals from different
chemicals, but statistical pattern recognition techniques for data
reduction and analysis (13,16–18) show that useful metabolic
information can be obtained for macronutrient metabolism (19).
Such studies demonstrated that 1H-NMR spectroscopy of human
plasma discriminates individuals with CVD based upon differ-
ences in lipid content (20,21) and that the approach can be used
for clinical measurement of blood lipids (22,23).
The present research was designed as a pilot study to test the
hypothesis that dietary SAA content altered postprandial macro-
nutrient metabolism as measured by 1H-NMR spectroscopy of
human plasma. The study was conducted concurrently with
research to determine the effects of SAA content on postprandial
redox potentials (10). In this research, we used a semisynthetic,
chemically defined diet based upon the studies of Fukagawa et al.
(24), Raguso et al. (25), and Lyons et al. (26), which allowed
specific changes in Met and Cys content while controlling total
energy and protein nitrogen (amino acid) content. Healthy
participants were studied while consuming food without SAA
and under comparable conditions with SAA (Met:Cys, 2:1) at an
amount (56 mg×kg21×d21) approximating the mean American
intake. The study design also provided postprandial measurements
obtained after 3-d equilibration to a SAA-free or replete diet to
determine whether recent history of SAA intake could affect
postprandial responses.
Materials and Methods
Human participants. This study was reviewed and approved by the
Emory Investigational Review Board and was performed in accordance
with the ethical standards of Emory University and the Emory IRB. The
study was performed in the Emory University Hospital General Clinical
Research Center (GCRC) as previously described (10). Eight participants
(5 male, 3 female) aged 18–36 y were studied (Supplemental Table 1).
Fourwere African American, 3were white, and 1was Asian. Age (mean6
SD) was 25 6 6 y. BMI ranged from 20 to 26 (22.5 6 2.1). Participants
reported no acute or chronic illness and none were taking regular pre-
scription medications.
A 3-d equilibration period with meals prepared by the GCRC
Bionutrition Unit and providing the RDA for SAA (12.2 mg×kg21 Met
plus 6.6 mg×kg21 Cys) and other amino acids was used to normalize
participants with regard to diet. Participants were admitted as inpatients
to the GCRC in the evening prior to initiation of the study. The study
involved successive phases in which participants received 0 mg×kg21 ×d21
SAA for 5 d followed by 56 mg×kg21×d21 SAA for 5 d, with a distribution
of Met:Cys of 2:1 (Supplemental Fig. 1). The protein equivalents were
supplied in the form of L-amino acid mixtures (Ajinomoto USA) providing
1.0×g×kg21×d21 (25,26). To compensate for the difference in Met + Cys
between the equilibration, 0 and 56 mg×kg21×d21 SAA diets, the amount
of all nonessential amino acids was proportionally changed to maintain a
constant dietary nitrogen content while maintaining them as isoenergetic
(10). Blood samples were taken from fasting participants daily at 0830.
On days without kinetic analysis, meals were provided at 0830, 1230, and
1730 h, and a snack at 2230. On d 1 and d 5 of each study period, all
participants were provided a single meal that combined the energy intake
of themorning andmiddaymeals and postprandial samples were collected
at 0930, 1030, 1130, 1230, 1430, and 1630 h (Supplemental Fig. 1). The
participants finished the study on d 5 after the 1630 time point, so the final
24-h time point on d5 of repletion was not available. Adequate hydration
and vitamin, mineral, and electrolyte requirements were provided to all
participants to meet or exceed recommended allowances (25) and body
weights were determined daily and vital signs were obtained every 8 h.
FIGURE 1 Principal component analysis of 1H-NMR spectra of
human plasma that were averaged for 8 participants at each time point
during sulfur amino acid (SAA)-depletion and SAA-repletion study
periods. (A) Two-dimensional score plot. (B) Loading plot correspond-
ing to A. The principal components (PC1 and PC2) are unit free. Some
of the regions (illustrated by circles in B) contributed to separation
according to SAA content of food. These included spectral regions
associated with LDL and VLDL (1.25, 1.29), cholesterol (0.91), lipid (1.30,
1.32), unsaturated lipid (5.23), lactate (1.33), and amino acids (3.15,
3.24). (C) Representative spectra illustrating change due to SAA-free
meal 2 h after eating. Spectrum for 1030 during SAA-free period is
shown in the upper panel and the corresponding spectrum for the
SAA-replete period is shown in the lower panel. (D) Difference
spectrum created by subtracting SAA-replete spectrum from SAA-free
spectrum (1030 time points, C) illustrates spectral regions affected by
dietary SAA. The predominant 2 peaks are associated with lipids.
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Sampling and analyses. Blood samples were collected, processed, and
stored as previously described (11). A total of 34 samples were collected
from each of 5 participants; 25 samples were available from a participant
who discontinued after d 8, and 33 and 32 samples were available for 2
participants who left early on d 10. Two samples were excluded because
of hemolysis. Consequently, the data analyzed were from a total of 258
samples.
For analysis, plasma samples (600 mL) were mixed with 66 mL of
D2O containing 3-(trimethylsilyl)-1-propanesulfonic acid sodium salt
(C6H15NaO3SSi, 1% wt:wt), and
1H-NMR spectra were measured at
600MHz on a Varian INOVA 600 spectrometer under conditions where
stability and reproducibility of the NMR analysis were previously
established (11). Preprocessing of 1H-NMR spectra was performed to
provide baseline-corrected, aligned, and normalized spectra containing
11,708 data points (11). Briefly, this included baseline correction with a
polynomial regression (NUTS program, Acorn NMR), spectral align-
ment using a beam search algorithm (27) to enhance the computational
efficiency of the genetic algorithm (28), elimination of uninformative
spectral regions, and normalization relative to the internal standard.
Chemicals contributing to plasma 1H-NMR spectra have been described
in detail (29); we reconfirmedmajor signals (11) using addition of known
standards (amino acids, sugars, organic acids, energy intermediates),
comparisons to spectra in chemical databases, analysis with Chenomx
software, and validation with 2-dimensional (2-D) NMR techniques.
Additional analyses of lipid fractions were consistent with the results of
Ala-Korpela et al. (22,23).
Lipid analyses were done using a Beckman CX7 automatic chemistry
analyzer. Plasma cholesterol and TG were measured by enzymatic
methods using reagents from Beckman Diagnostics. HDL-cholesterol
and LDL-cholesterol were measured by homogeneous enzymatic
methods. Immunoturbinometric methods were used for high-sensitivity
C-reactive protein (hsCRP; Equal Diagnostics), ApoC-III (Wako Chem-
icals) and ApoB (diaSorin). TG and phospholipids were quantified by
liquid chromatography-MS in the positive ion mode. For analysis, 10 mL
was injected onto an Ultrasphere 5 mm Spherical 80 Å pore C-18 (2.0 3
150mm; Beckman Coulter) columnwith a Targa C18 precolumn (Higgins
Analytical) for desalting and optimum chromatographic resolution. The
flow rate was 0.5 mL×min21 with 5% water/95% acetonitrile with 0.1%
formic acid for 15 min. The eluate from the HPLC was connected to a
Thermo LTQ-FTmass spectrometer (Thermo-Fisher Scientific). The LTQ-
FT used an atmospheric pressure chemical ionization source that was
operated with a source current of 5 mA, atmospheric pressure chemical
ionization vaporization temperature of 4508C, sheath gas setting of 50
(arbitrary units), auxiliary gas setting of 50 (arbitrary units), capillary
temperature of 2758C, capillary voltage of 35 V, and tube lens of 55 V.
Analyses were done using theMSmode scanning fromm/z 500 to 1000 in
the FT detector at a resolution of 50,000 with the wide range scan mode
and 400,000 ions/scan.Maximum ion injection time was 500 ms. Triolein
(1,1,1-13C3, 99%; Cambridge Isotope Laboratories) was used as an
internal standard.
Bioinformatics and statistics. Data reduction by a principal compo-
nent (PC) analysis (PCA) was performed using Pirouette software
(Infometrix) after centering the mean of each variable. A previous analysis
of diurnal variation in 1H-NMR spectra of human plasma showed that
individual differences in rates of absorption and clearance of dietary
components obscured common metabolic patterns, which were apparent
when spectra for respective time points were averaged to minimize the
contribution of inter-individual differences (11). Consequently, for anal-
yses as indicated, inter-individual variation was minimized by averaging
the intensity for the 8 participants at each of the 11,708 frequencies. Two-
dimensional PCA score and loading plots were used to visualize patterns
and discriminatory factors associated with SAA content. For supervised
analyses, variation not correlated to classification was removed with
orthogonal signal correction/partial least squares-discriminant analysis
(OPLS-DA) using Pirouette software (Infometrix) after centering the mean
value for each frequency (30–32). One of the limitations to the use of
OPLS-DA is that data can give a false impression of the accuracy of
classification, because class information is implicitly used to remove
variability of input data orthogonal to the response. To validate the OPLS-
DA classification model, a random permutation test was applied to obtain
misclassification counts and Q2, a measure for classification prediction
ability (33,34). This permutation test evaluates whether the specific
classification of the individuals in the 2 designed groups is significantly
better than any other random classification in 2 arbitrary groups. In the
OPLS-DA model, each time point (except baseline on d1) for d 1 and 5
was designated as SAA depletion, and each for d 6 and 10 was designated
as SAA repletion. Baseline on d 1 was designated as SAA repletion,
because this time point followed equilibration to adequate SAA intake.
To complement the use of loading plots in identification of spectral
regions that differ due to SAA-content of meals, false discovery rate (FDR)
(35,36) was performed using MATLAB. For spectral regions identified by
FDR, we integrated values associated with known plasma metabolites for
each individual to generate plots of relative changes in metabolite
concentration as a function of time. In the FDR model, we grouped the
data according to day of measurement as was done with the OPLS-DA
model. We performed a mixed model, repeated-measures ANOVA to
determine the effect of SAA, time, and the interaction of SAA and time
FIGURE 2 Orthogonal signal
correction partial least squares-
discriminant analysis (OPLS-DA) of
proton NMR (1H-NMR) spectra of
human plasma to identify spectral
regions that discriminate according
to dietary sulfur amino acid (SAA)
content. A shows the score plot
and B the corresponding loading
plot for all 258 spectra. (C,D) The
score plot and corresponding load-
ing plot of OPLS-DA for 181 spec-
tra obtained during the postprandial
periods at 0930, 1030, 1130, 1230,
1430, and 1630 h. The principal
components (PC1 and PC2) in A–D
are unit free. (B,D) The discrimina-
tory regions between SAA defi-
ciency and repletion on loading
plots are shown by circles. These
included signals associated with
lipid and amino acid (B,D). (E,F) Class model validation for OPLS-DA. In E, the arrow corresponds to the misclassification in the OPLS-model;
results for 3000 random permutations are shown in the histogram. In F, Q2 for the random permutation distribution is shown in the histogram and
was between –0.1 and 0.4. The arrow corresponds to the value for the OPLS-DA model.
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(SAA 3 time) and then used a paired t test for each frequency to find the
significant regions that discriminated between SAA depletion and reple-
tion at P, 0.05. For the lipid analyses, the same statistical procedure with
a mixed model, repeated-measures ANOVAwas performed to determine
the effect of SAA, time, and interaction of SAA and time followed by a
paired t test to find the significance for each time point that discriminated
between SAA depletion and repletion at P , 0.05. To obtain detailed
information on the effect of SAA in a single meal on postprandial plasma
metabolites, we compared each time point between d 1 and 10 (equil-
ibrated to SAA-containing food) and between d 5 and 6 (equilibrated to
SAA-free food) using mixed measures ANOVA and then paired t test as
described above.
Results
PCA of 1H-NMR spectra of plasma samples. PCA of spectra
for all 258 samples was performed to determine if differences
between SAA deficiency and SAA repletion periods were appar-
ent in macronutrient profiles. However, even though the first 2
PC accounted for 65% of the total variance, no separation was
evident between the study periods in the 2-D PCA score plot
(Supplemental Fig. 2A). Further examination of score plots for
different combinations of the first 9 PC did not reveal any
differences (not shown); however, some separation was apparent
for individuals when they were separately color-coded within
this analysis (Supplemental Fig. 3).
To determine whether response patterns to SAA deficiency
could be identified within individuals, PCA was performed
separately for the series of 34 spectra from each participant.
Results showed separation in 2-D PCA plots according to SAA
intake (Supplemental Fig. 2B–I). For some individuals, addi-
tional separation was visible in 3-D PCA plots in which the axes
were rotated to enhance visualization (Supplemental Fig. 4).
These data indicate that common response patterns are at least
partially obscured by inter-individual variation.
Examination of metabolic patterns in averaged 1H-NMR
spectra. To decrease contribution from inter-individual varia-
tion, spectra from the 8 individuals were averaged for each time
point to assess SAA-dependent metabolic changes. With this
averaged dataset for 34 time points, PCA results showed that
PC1 and PC2 accounted for 75 and 8% of variation, respec-
tively, and trajectories for SAA-free and SAA intake were sepa-
rated (Fig. 1A). The corresponding loading plot indicated that
major discriminatory regions for the SAA-free period included
those containing lipid (1.25, 1.29, 1.30, 1.32, and 5.23 ppm)
(Fig. 1B). This plot also indicated that signals associated with
amino acids (3.15, 3.24) contributed to the separation of the
SAA-sufficient period. These conclusions were verified by visual
inspection of the average spectra for the 1030 time point with
and without SAA (Fig. 1C), which showed differences in signal
intensities for these regions. The differences were also apparent
in the difference spectrum obtained by subtracting the average
spectrum with SAA from the average spectrum without SAA
(Fig. 1D).
OPLS-DA of 1H-NMR spectra according to SAA intake. To
more specifically examine spectral features that distinguished the
SAA-free and SAA-sufficient conditions, an orthogonal signal
correction method, OPLS-DA, was used to remove noncorrelated
variation. The results showed separation according to SAA con-
tent, with better separation for the postprandial data alone (Fig.
2C) than for the entire sample set (Fig. 2A). The large distance
between classes implies that the classificationmodel is sufficient to
separate classes from each other. The loading plots (Fig. 2B,D)
confirmed that discriminatory regions included lipid and amino
acid signals, which were represented by circles. These analyses
further indicated that spectral regions associated with VLDL
(1.29 ppm) and cholesterol (0.91 ppm) contributed to the
discrimination due to SAA. These supervised analyses also
showed contributions due to lactate (1.33 ppm) and amino acids
TABLE 1 Regions of 1H-NMR spectra of human plasma
with significant differences due to SAA intake
according to false discovery rate (FDR) analysis1
Region (ppm) Possible feature Assignment P
Lipid signals
0.66 Cholesterol C18 (in HDL) 0.002
0.70 Cholesterol C18 (in VLDL) ,0.001
0.84 Lipid (mainly LDL) C26 and C27 ,0.001
0.91 Cholesterol C21 0.002
0.93 Lipid CH3CH2 ,0.001
1.22 Lipid CH3CH2CH2 ,0.001
1.25 Lipid CH3CH2(CH2)n 0.006
1.29 Lipid (mainly VLDL) CH2CH2CH2CO ,0.001
1.30 Lipid CH2 0.004
1.32 Lipid CH2CH2CH2CO 0.004
1.97 Lipid CH2C = C 0.008
2.00 Lipid CH2C = C ,0.001
2.72 Lipid C = CCH2C = C 0.009
3.66 Choline (lipid) NCH2 ,0.001
5.23 Unsaturated lipid CH = CHCH2CH = CH ,0.001
5.26 Unsaturated lipid CH = CHCH2CH = CH ,0.001
5.27 Unsaturated lipid =CHCH2CH2 ,0.001
5.29 Unsaturated lipid CH = CHCH2CH = CH ,0.001
5.31 Unsaturated lipid =CHCH2CH2 ,0.001
5.33 Unsaturated lipid =CHCH2CH2 ,0.001
Amino acid signals
0.93 Isoleucine d-CH3 0.003
0.95 Leucine d-CH3 0.002
0.97 Leucine d-CH3 0.002
0.97 Valine CH3 ,0.001
1.00 Isoleucine b-CH3 0.004
1.02 Valine CH3 ,0.001
1.28 Isoleucine half g-CH2 0.003
1.99 Proline g-CH2 ,0.001
2.00 Glutamate half b-CH2 ,0.001
2.05 Proline half b-CH2 ,0.001
2.08 Glutamine half b-CH2 ,0.001
2.09 Glutamine half b-CH2 ,0.001
2.81 Aspartate half b-CH2 0.009
3.15 Citrulline g-CH2 0.009
3.24 Arginine d-CH2 0.002
3.94 Tyrosine a-CH 0.009
4.12 Proline a-CH ,0.001
Other signals
1.13 Isobutyrate CH3 ,0.001
1.20 3-Hydroxybutyrate g-CH3 ,0.001
1.33 Lactate CH3 0.004
4.11 Lactate CH ,0.001
3.21 Choline N(CH3)3 ,0.001
4.13 3-Hydroxybutyrate b-CH 0.002
2.04 Glycoprotein NHCOCH3 ,0.001
1 Spectral regions with significant differences are associated with major plasma
metabolites known to have H-NMR signal with the respective ppm. Regions are
grouped according to common macronutrient groups.
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(isoleucine, 1.00; valine, 1.02; glutamine, 2.09) (29). A histogram
showing misclassification for 3000 randomly permuted data is
shown in Figure 2E along with misclassification for the OPLS-DA
model, shown by an arrow. Q2 for the random permutation
distribution is shown by the histogram in Figure 2F and the
original OPLS-DA classification is indicated by the arrow.
FDR analysis of spectral differences due to SAA content of
food. As an alternative means to test for spectral frequencies
that contributed significantly to discriminate based upon SAA
intake, we used a multiple testing procedure based on the
concept of the FDR (35,36). Results of this analysis (Table 1)
showed several frequencies associated with lipid regions, in-
cluding those of cholesterol, SFA, unsaturated fatty acids, LDL
cholesterol, VLDL cholesterol, and HDL cholesterol, were sig-
nificantly different according to SAA intakes. This analysis also
showed significant differences in spectral regions associated with
lactate and amino acids (Table 1). Taken together with the un-
supervised and supervised data reduction approaches, these sta-
tistical analyses show that consumption of SAA-free food has
effects on postprandial plasma concentrations of lipids and
amino acids as measured by 1H-NMR spectroscopy.
Postprandial time course of signal changes in selective
regions due to SAA-free meal. To visualize changes with time
in spectral regions identified by FDR, we integrated signals within
individual spectra corresponding to known metabolites and then
constructed plots to test for changes due to SAA depletion in the
postprandial period for the study periods equilibrated to adequate
SAA intake (Fig. 3). Using a mixed model, repeated-measures
ANOVA, effects of time and SAA intake were observed for signals
corresponding to lipids (Fig. 3A–C; 0.91 and 1.25, 1.29, 5.23
ppm; P , 0.0001). However, signals for amino acids differed in
response characteristics, with alanine showing an effect of time
but not SAA (Fig. 3D), whereas isoleucine (Fig. 3E; P , 0.001)
and valine (Fig. 3F; P, 0.001) showed an effect of SAA and time.
The values for the major ppm regions corresponding to glucose
showed no effect of time or SAA (Fig. 3G; P , 0.35), but the
region associated with lactate showed effects with both time and
SAA (Fig. 3H; P , 0.005).
Measurement of blood lipids in the postprandial period by
conventional analysis. To confirm the results of 1H-NMR
spectroscopy showing that consumption of SAA-free food re-
sulted in higher plasma lipids, we used conventional chemical
analysis for TG, total phospholipids, cholesterol, HDL, LDL,
apoB, apoC-III, and hsCRP plasma concentrations. The results
for the postprandial period equilibrated with adequate SAA diet
were analyzed by repeated-measures ANOVA (Fig. 4). The
plasma concentrations of TG and ApoC-III were different by
dietary SAA contents and time after meal (Fig. 4; P , 0.05).
Plasma cholesterol levels showed no difference by repeated-
measures ANOVA, but showed a trend (P = 0.057) by paired t test
at 4 h. Postprandial phospholipid concentrations did not signif-
icantly differ (Fig. 4C), and no significant differences according to
SAA intake were observed for plasma HDL, LDL, apoB, or
hsCRP levels (data not shown). Analysis following equilibration
to SAA-free food also showed significant effects of SAA content
FIGURE 3 Time-dependent changes in amplitude of selected spectral regions of human plasma proton NMR (1H-NMR) spectra in the
postprandial period following a meal without or with sulfur amino acid (SAA). Regions were selected from those identified as significant in false
discovery rate (FDR) analysis (Table 1) and are shown for the postprandial effect of dietary SAA content on d 1 and 10, which were equilibrated to
adequate SAA intake. (A) Regions of LDL+VLDL centered at 1.25 and 1.29 ppm. (B) Region of unsaturated lipid centered at 5.23 ppm. (C) Region
of cholesterol centered at 0.91 ppm. (D) Region of alanine centered at 1.46 ppm. (E) Region of isoleucine centered at 0.93 and 1.00 ppm. (F)
Region of valine centered at 0.97 and 1.02 ppm. (G) Region of b-glucose centered at 3.24 ppm. (H) Region of lactate centered at 1.33 ppm. To
determine the effect of SAA, time, and the interaction of SAA and time, a mixed model, repeated-measures ANOVA was performed. Significant
main effects were SAA and time (A–C,E,F,H) or time (D). *Different from SAA-free at that time, P , 0.05.
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on postprandial plasma TG and cholesterol (repeated measure-
ment ANOVA; data not shown). Thus, direct lipid analyses
confirmed that plasma TG were higher following consumption of
SAA-free food.
Additional information on changes in amounts of TG and
phospholipid due to dietary SAA status were obtained using LC-
MS. This method allowed detection of TG and phospholipid
species in a small volume (10 mL), but most of these did not reveal
significant differences in the small number of samples available
for analysis. The TG 16:0/16:0/20:4 (Supplemental Fig. 5) show-
ed the same pattern of intensity change as that observed by 1H-
NMR spectroscopy (Fig. 3A) and conventional analysis (Fig. 4A).
However, phosphatidylcholine, 14:1(9Z)/14:1(9Z) (Supplemental
Fig. 6), showed a trend opposite to that for total phospholipid
analysis (Fig. 4C).
Discussion
The present study used 1H-NMR spectroscopy of plasma to test
for metabolic changes associated with intake of a SAA-free diet in
humans. The spectroscopic method requires minimal sample
processing and no chemical derivatization, allowing a rapid char-
acterization of changes in high-abundance plasma metabolites.
The method is attractive for development of personalized nutri-
tional challenge protocols, because automated analysis with
computer-based algorithms could provide near real-time evalu-
ation of gastrointestinal dysfunction and macronutrient malab-
sorption. In previous studies, the method has been used for
detection and quantification of metabolites related to fat, car-
bohydrate, and protein nutrition (37–39).
A key finding of the present study is that 1H-NMR spectros-
copy can be used to study macronutrient metabolism following a
meal challenge, specifically detecting lipid changes in the post-
prandial period upon consumption of a nutritionally imbalanced
(SAA-free) meal. Although beyond the scope of this study, de-
tailed studies of the SAA-dependent lipid changes are needed to
understand this effect, because the 1H-NMR analysis provides
global information, discriminating some lipid classes but not
individual lipid species. This point is illustrated by the MS
finding that change in a specific phosphatidylcholine did not
match the total phospholipid analysis.
Plasma TG were increased by SAA-free food even though the
content of fat was equivalent in the 2 diets. Because the total
carbohydrate and amino acid-nitrogen were also constant, the
data indicate that variables linked to Met or Cys, or some aspect
of the amino acid imbalance created by SAA-free food, affects
plasma concentrations of these lipids. Importantly, the changes in
postprandial TG and apoC-III were immediate and seen after a
single meal with SAA-free food. We have previously observed
Cys/CySS redox effects on metalloproteinase activity and cell
surface receptor (40), but in the present studies, we have no
mechanistic evidence linking diet-dependent redox changes to
changes in lipid metabolism.
The measured change in apoC-III, a known inhibitor of
lipoprotein lipase responsible for TG hydrolysis (41), suggests
that effects on TG concentrations could be mediated in part
through interference with TG hydrolysis or increased TG pro-
duction. Lipoprotein lipase is an enzyme produced in fat cells
(adipocytes) and bound to the walls of capillaries. It breaks
down triacylglycerols (TG) into FFA and monoglycerides, which
can enter cells for storage. Changes in the N-methylation of
phosphatidylethanolamine, which can be affected by SAA (1,2),
alter the composition of surface lipids on the TG-rich lipopro-
teins and thus affect the binding affinity of apoC-III. The rapid
increase in apoC-III following the consumption of the first SAA-
free meal would suggest that increased apoC-III production is
unlikely to be responsible for this effect. These findings suggest a
need for additional studies designed specifically to examine the
role of dietary SAA on the regulation of TG metabolism.
As previously recognized, differences in rates of gastric emp-
tying, intestinal absorption, and clearance of metabolites can
affect plasma time courses on an individual basis (11). Individual
differences are also apparent in the trajectories for individuals in
the PCA due to SAA-free food. Individual trajectories in the PCA
FIGURE 4 Effects of sulfur amino acid (SAA) content of meal on
postprandial human plasma TG (A), cholesterol (B), phospholipids (C ),
and lipoprotein lipase inhibitor, apoC-III (D) following 3-d equilibration to
a diet with adequate SAA content. Data are expressed as percentage of
respective premeal concentration for each individual. Dietary SAA
intake was 56 mg×kg21×d21. Values are given as mean 6 SEM, n = 8.
To determine the effect of SAA, time, and the interaction of SAA and
time, a mixed model, repeated-measures ANOVA was performed.
Significant main effects were SAA and time (A) or SAA, time, and
SAA 3 time (D). *Different from SAA-free at that time, P , 0.05.
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of all 256 samples show that individual metabolic responses
differ even though all participants were studied under identical
clinical research conditions and fed identical food. Research will
be needed to characterize time courses and magnitudes of change
for specific spectral regions to study dietary responses associated
with risk of CVD or other disease process.
Metabolic effects of inadequate intake of an essential amino
acid, Met, are expected due to an ensuing amino acid deficiency.
However, deficiency does not occur with a single meal, so the
altered amino acid signals probably reflect an amino acid im-
balance of the meal rather than a nutritional deficiency. Sur-
prisingly, the plasma 1H-NMR spectra showed that differences
occurred in spectral regions associated with the essential amino
acids isoleucine and valine, for which consumption was constant
in the SAA depletion and SAA repletion periods. Although such
changes in plasma amino acid concentrations in response to
altered dietary SAA intake need independent validation, the
complex patterns of response indicate that sophisticated bio-
informatic analyses will be required for interpretation of meta-
bolic profiles in dietary challenge studies.
The complexity of individual metabolic responses to dietary
SAA content reinforces the need to improve metabolic profiling
capabilities for individual health evaluation. Loscalzo et al. (42)
addressed the inadequacies of contemporary approaches to address
pathobiology of complex systems at the level of an individual.
Information-rich metabolic profiling methods, such as 1H-NMR
spectroscopy, can support new systems biology approaches in
personalized medicine by providing a simple and reproducible
approach to gain quantitative information on macronutrients in
plasma. This measurement can be automated for routine use (38)
and is complementary to MS and chemical approaches that mea-
sure individual metabolites (43).
In summary, the present study shows that 1H-NMR spec-
troscopy of human plasma can be used to evaluate macronutri-
ent metabolism in a controlled meal challenge study. The results
showed that lipid concentrations in humans are higher in the
postprandial period following consumption of food without
SAA. The results indicate a need to more specifically evaluate
possible effects of SAA intake, as well as amino acid balance, on
postprandial lipid concentrations in disease mechanisms.
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